Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma - Related Studies

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00004033. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Malignant Mesothelioma

2	Additional conditions recognized in this trial
		Mesothelioma

3	More general conditions related to this trial
		Adenoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial

4	Interventions listed in this trial
		liposomal NDDP
		thoracoscopic surgery

5	Sponsors listed in this trial
		New York University School of Medicine
		National Cancer Institute (NCI)